Tanabe Pharma Corp - Company Profile
Powered by 
All the sales intelligence you need on Tanabe Pharma Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Tanabe Pharma Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Tanabe Pharma Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Tanabe Pharma Corp (Tanabe), formerly Mitsubishi Tanabe Pharma Corp, a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures, and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune diseases, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Tanabe is headquartered in Osaka, Japan.
Headquarters
Japan
Address
3-2-10, Dosho-machi, Chuo-ku, Osaka, 541-8505
Website
www.mt-pharma.co.jp
Telephone
81 6 62055085
Industry
Pharmaceuticals and Healthcare
Tanabe Pharma Corp premium industry data and analytics
Products and Services
| Products |
|---|
| Autoimmune Diseases: |
| Stelera |
| Simponi (golimumab): Rheumatoid Arthritis |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In July, the company entered into an agreement to sell Tanabe Pharma Factory Co., Ltd to Towa Pharmaceutical Co., Ltd. |
| 2026 | Acquisitions/Mergers/Takeovers | In April, the company acquired all rights for RADICAVA (edaravone), including intellectual property rights and sales rights from Tanabe Pharma Corporation. |
| 2025 | Regulatory Approval | In October, the company received approval to change its corporate name to Tanabe Pharma Corporation, effective December 1. |
Competitor Comparison
| Key Parameters | Tanabe Pharma Corp | Astellas Pharma Inc | Daiichi Sankyo Co Ltd | Chugai Pharmaceutical Co Ltd | Taisho Pharmaceutical Holdings Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | - | Chuo-Ku | Chuo-Ku | Chuo-Ku | Toshima |
| State/Province | Osaka | Tokyo | Tokyo | Tokyo | Tokyo |
| No. of Employees | - | 13,643 | 19,765 | 7,872 | 8,784 |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Costa Saroukos | Chairman | Executive Board | 2025 | - |
| Akihisa Harada | Director; Chief Executive Officer | Executive Board | 2025 | - |
| Tsujimura Akihiro | President; Chief Operating Officer; Director | Executive Board | 2025 | - |
| Amit Singh | Chief Financial Officer; Head - Finance | Senior Management | 2025 | - |
| Keitarou Shigemasa | Chief Information Officer; Head - IT Digital Division | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer